Cortexyme, inc. (CRTX)
CashFlow / Yearly
Dec'19Dec'18
Cash flows from operating activities:
Net Loss

-36,980

-12,476

Adjustments to reconcile net loss to net cash used in operating activities:
Non-cash interest expense related to convertible promissory notes

-

263

Non-cash rent expense

367

153

Stock based compensation

2,056

155

Depreciation and amortization

188

51

Accretion of discount on convertible promissory notes payable

-

694

Amortization of discount on available for sale investments

812

351

Change in fair value of derivative liability

-

-206

Changes in operating assets and liabilities:
Prepaid expenses and other current assets

5,324

690

Other assets

207

-50

Accounts payable

2,580

-23

Accrued expenses and other current liabilities

4,855

273

Net cash used in operating activities

-33,277

-11,695

Cash flow from investing activities:
Purchase of investments

135,415

55,242

Proceeds from maturities of investments

117,723

8,700

Purchase of property and equipment

55

212

Net cash (used in) provided by investing activities

-17,747

-46,754

Cash flows from financing activities:
Payments of finance leases

559

-

Proceeds from issuance of convertible promissory note payable

-

250

Proceeds from issuance of common stock upon exercise of stock options

97

24

Proceeds from Series B redeemable convertible preferred stock, net of issuance costs

-

75,688

Proceeds from stock warrant exercise

1

-

Deferred initial public offering costs

-

34

Proceeds from initial public offering, net of stock offering costs

77,827

-

Net cash provided by financing activities

77,366

75,928

Net change in cash and cash equivalents

26,342

17,479

Supplemental disclosures of non-cash information:
Right-of-use assets obtained in exchange for new operating lease liabilities

878

-

Series A Redeemable Convertible Preferred Stock
Conversion of redeemable convertible preferred stock to common stock on initial public offering

17,178

-

Series B Redeemable Convertible Preferred Stock
Conversion of redeemable convertible preferred stock to common stock on initial public offering

87,816

-

Acceleration of vesting of stock on initial public offering

856

-

Issuance of stock in connection with conversion of convertible promissory notes and accrued interest

-

11,027

Issuance of stock for facility lease

-

1,100